Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

KalVista Pharmaceuticals (KALV) Amortizatization of Intangibles (2016 - 2025)

Historic Amortizatization of Intangibles for KalVista Pharmaceuticals (KALV) over the last 8 years, with Q2 2025 value amounting to $3000.0.

  • KalVista Pharmaceuticals' Amortizatization of Intangibles fell 2500.0% to $3000.0 in Q2 2025 from the same period last year, while for Apr 2025 it was $17000.0, marking a year-over-year decrease of 8152.17%. This contributed to the annual value of $14000.0 for FY2025, which is 8478.26% down from last year.
  • According to the latest figures from Q2 2025, KalVista Pharmaceuticals' Amortizatization of Intangibles is $3000.0, which was down 2500.0% from $5000.0 recorded in Q4 2024.
  • In the past 5 years, KalVista Pharmaceuticals' Amortizatization of Intangibles ranged from a high of $62000.0 in Q3 2023 and a low of $3000.0 during Q2 2025
  • Moreover, its 3-year median value for Amortizatization of Intangibles was $5000.0 (2024), whereas its average is $15000.0.
  • As far as peak fluctuations go, KalVista Pharmaceuticals' Amortizatization of Intangibles crashed by 9193.55% in 2024, and later tumbled by 2500.0% in 2025.
  • Quarter analysis of 3 years shows KalVista Pharmaceuticals' Amortizatization of Intangibles stood at $21000.0 in 2023, then crashed by 76.19% to $5000.0 in 2024, then plummeted by 40.0% to $3000.0 in 2025.
  • Its Amortizatization of Intangibles stands at $3000.0 for Q2 2025, versus $5000.0 for Q4 2024 and $5000.0 for Q3 2024.